Participatory Disease Surveillance: Engaging Communities Directly in Reporting, Monitoring, and Responding to Health Threats.

JMIR Public Health Surveill

Skoll Global Threats Fund, Ending Pandemics, San Francisco, CA, United States.

Published: October 2017

Background: Since 2012, the International Workshop on Participatory Surveillance (IWOPS) has served as an informal network to share best practices, consult on analytic methods, and catalyze innovation to advance the burgeoning method of direct engagement of populations in voluntary monitoring of disease.

Objective: This landscape provides an overview of participatory disease surveillance systems in the IWOPS network and orients readers to this growing field of practice.

Methods: Authors reviewed participatory approaches that include human and animal health surveillance, both syndromic (self- reported symptoms) and event-based, and how these tools have been leveraged for disease modeling and forecasting. The authors also discuss benefits, challenges, and future directions for participatory disease surveillance.

Results: There are at least 23 distinct participatory surveillance tools or programs represented in the IWOPS network across 18 countries. Organizations supporting these tools are diverse in nature.

Conclusions: Participatory disease surveillance is a promising method to complement both traditional, facility-based surveillance and newer digital epidemiology systems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658636PMC
http://dx.doi.org/10.2196/publichealth.7540DOI Listing

Publication Analysis

Top Keywords

participatory disease
16
disease surveillance
12
participatory surveillance
8
iwops network
8
participatory
7
surveillance
7
surveillance engaging
4
engaging communities
4
communities directly
4
directly reporting
4

Similar Publications

Objectives: COVID-19 vaccine was rolled out for the public in August 2021 in Zamfara state, Northen Nigeria. We determined the factors influencing COVID-19 vaccine acceptance.

Settings: We executed a community-based analytical cross-sectional study during the first 4 months of the second phase of the COVID-19 (Oxford/AstraZeneca) mass vaccination campaign in Zamfara state.

View Article and Find Full Text PDF

Background: People with disabilities due to neglected tropical diseases (NTDs), such as leprosy and lymphatic filariasis (LF), often encounter situations of stigma and discrimination that significantly impact their mental wellbeing. Mental wellbeing services are often not available at the peripheral level in NTD-endemic countries, and there is a need for such services. Basic psychological support for persons with NTDs (BPS-N) from peers is an important potential solution for addressing mental wellbeing problems.

View Article and Find Full Text PDF

Background: Black/African American women are the most at-risk demographic group for developing Alzheimer's disease and related dementias (ADRD). Unfortunately, Black Americans are underrepresented in research, accounting for just 8% of clinical trial participants in the USA. Restrictive study exclusion criteria and medical mistrust are pervasive barriers to research participation in minoritized communities and are often disregarded during the development of a research study.

View Article and Find Full Text PDF

Background: Asian Americans and Asian Canadians (ASACs) are the fastest growing minority group in the US and Canada. However, ASACs are under-sampled in Alzheimer's disease (AD) research. To address the need of culturally appropriate clinical protocols and community-based recruitment approaches for ASACs, the Asian Cohort for Alzheimer's Disease (ACAD), the first large dementia genetics cohort focusing on Chinese, Korean, and Vietnamese, launched in 2021 to examine genetic and non-genetic risk factors for AD among ASACs.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

American Samoa Community, Pago Pago, AS, American Samoa.

Background: The Puipui Malu Manatu (PMM) study (RF1AG075904) is determining Alzheimer's Disease and Related Dementias (ADRD) prevalence by administering cognitive assessment tools and determining prevalence of known genetic and plasma biomarkers. The sampling method uses a cluster and selection process to obtain a randomized sample of 1089 adults that is generalizable to the population. Research hesitancy exists due to historical abuse of non-Indigenous researchers conducting studies that are not reflective of the community health needs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!